Professor Soehartati Gondhowiardjo, a leading expert in radiation oncology, has been named to the distinguished faculty of the 14th Asia-Pacific Breast Cancer Summit (APBCS 2026). The announcement recognizes Professor Gondhowiardjo’s extensive contributions to the field and her commitment to advancing cancer care in the Asia-Pacific region.
A Career Dedicated to Oncology
Professor Gondhowiardjo is a Professor and Senior Consultant in Radiation Oncology at Cipto Mangunkusumo National General Hospital (RSCM) and the Faculty of Medicine, University of Indonesia, Jakarta. She also currently serves as a member of the Standing Advisory Group on Nuclear Applications (SAGNA) at the International Atomic Energy Agency (IAEA).
Her leadership extends to regional collaboration, as she is the Co-Founder and Past President of the Federation of Asian Organizations for Radiation Oncology (FARO), South-East Asian Radiation Oncology Group (SEAROG), and the Indonesian Radiation Oncology Society (IROS). Her academic work focuses on multiple disease sites, including nasopharyngeal, paediatric, and breast cancers.
Implications for Regional Cancer Care
Professor Gondhowiardjo’s involvement with APBCS 2026 could further elevate the summit’s focus on improving access to and the quality of radiotherapy. Her experience with national cancer policy and strategy may inform discussions around regional best practices. The summit is scheduled to take place February 6–8, 2026, at St Giles Wembley, Penang.
Individuals interested in attending APBCS 2026 can register now.
Frequently Asked Questions
What is the focus of Professor Gondhowiardjo’s academic work?
Her academic work spans multiple disease sites, with a particular focus on nasopharyngeal, paediatric, and breast cancers.
Where will the 14th Asia-Pacific Breast Cancer Summit (APBCS 2026) be held?
APBCS 2026 will take place at St Giles Wembley, Penang.
What organizations has Professor Gondhowiardjo led?
She is the Co-Founder and Past President of the Federation of Asian Organizations for Radiation Oncology (FARO), South-East Asian Radiation Oncology Group (SEAROG), and the Indonesian Radiation Oncology Society (IROS).
How might increased regional collaboration impact cancer treatment outcomes in the Asia-Pacific region?
